Brand Name: SGONEK
Price: $1 -$2/Gram
Place of Origin: Shaanxi, China
Certification: ISO FDA SG COA MSDS
Grade: Food Grade, Medicine Grade, Heparin Sodium
Payment Terms: T/T, Western Union, MoneyGram
Product Name: | Heparin Sodium | Cas No.: | 9041-08-1 |
Molecular Formula: | C24H27Cl3FN5O3 | Purity: | 99%min |
Brand Name: | SGONEK | Certification: | ISO FDA SG COA MSDS |
Product Name | Heparin Sodium |
CAS No. | 9041-08-1 |
Purity | 99% |
Appearance | White Crystalline Powder |
Molecular Formula | C24H27Cl3FN5O3 |
EINECS No. | 618-546-9 |
Description: Heparin, a sulphated glucosaminoglycan, is widely distributed in mammalian liver, lungs, heart, kidney, the thymus, spleen, intestinal mucosa, muscle and blood. So it can be extracted from porcineintestine or bovine lung or porcine lung. Heparin sodium produced by our company is extracted from porcine intestine. It has the characteristic property of delaying the clotting of freshly shed blood. |
Items |
Specifications |
Results |
Appearance |
White or milk whitecrystalline porder |
Qualified |
Identification |
Must pisitive |
Positive |
Odor |
Characteristicless |
Qualified |
Colour of solution |
Must qualified |
Qualified |
Related substances |
Must qualified |
Qualified |
Residual Solvent |
≤0.5% |
Qualified |
Acidity or alkalinity(PH) |
4.5-7.0 |
6.0 |
Absorptivity |
137 - 147 |
145 |
Optical rotation |
-1.27° -1.34° |
1.31° |
Heavy metals |
≤20ppm |
<20ppm |
Losson drying |
≤0.5% |
0.35% |
Sulphated ash |
≤0.1% |
0.05% |
Assay |
99.0-101.0% |
99.98% |
1. The treatment of various diseases concurrent disseminated intravascular coagulation early.
2. Prevention of arterial and venous thrombosis and pulmonary embolism.
3. Treatment of arterial and venous thrombosis and pulmonary embolism, ischemic stroke, unstable angina (to
alleviate the symptoms, prevention of myocardial infarction), acute myocardial infarction (prevention of early
reinfarction and infarct extension, reduce mortality).
4. The artificial lung, peritoneal dialysis or hemodialysis as anticoagulants.
5. thrombolytic therapy as maintenance therapy.
6. used for the prevention of blood coagulation and blood bank transfusion of blood and other body save
anticoagulants.